Genix Pharmaceuticals Corporation
GENPF · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11 | $12 | $9 | $139 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $6 | $1 | $0 | $5 |
| Inventory | $0 | $159 | $171 | $5 |
| Other Curr. Assets | $22 | $43 | $43 | $40 |
| Total Curr. Assets | $39 | $216 | $240 | $188 |
| Property Plant & Equip (Net) | $0 | $0 | $4 | $32 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $7 | $8 | $4,008 | $4,549 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | -$0 | -$4,012 | -$4,581 |
| Total NC Assets | $7 | $8 | $4,012 | $4,581 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $46 | $223 | $4,253 | $4,769 |
| Liabilities | – | – | – | – |
| Payables | $150 | $249 | $213 | $12 |
| Short-Term Debt | $816 | $512 | $183 | $38 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $22 | $32 |
| Other Curr. Liab. | $264 | $600 | $658 | $695 |
| Total Curr. Liab. | $1,229 | $1,361 | $1,054 | $744 |
| LT Debt | $0 | $0 | $0 | $11 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $11 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $5 | $34 |
| Total Liabilities | $1,229 | $1,361 | $1,054 | $755 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $9,701 | $9,701 | $9,701 | $9,701 |
| Retained Earnings | -$12,204 | -$12,131 | -$7,735 | -$6,661 |
| AOCI | $0 | $1,293 | $1,233 | $975 |
| Other Equity | $1,320 | $0 | $0 | $0 |
| Total Equity | -$1,183 | -$1,137 | $3,199 | $4,014 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $46 | $223 | $4,253 | $4,769 |
| Net Debt | $804 | $500 | $173 | -$90 |